Case Report: Left ventricular thrombosis during venoarterial extracorporeal membrane oxygenation for fulminant myocarditis in a 9-year-old boy

Background Left ventricular (LV) thrombosis is uncommon during venoarterial extracorporeal membrane oxygenation (VA-ECMO) in children. Management is especially difficult when intracranial hemorrhage limits anticoagulation, and pediatric evidence is sparse. Case presentation A 9-year-old boy (25 kg) with fulminant myocarditis and cardiogenic shock underwent VA-ECMO with surgical LV decompression. Unfractionated heparin (UFH, 10 U/kg/h) was initially stopped for pleural-drain bleeding, resumed at low dose, and stopped again after parafalcine subarachnoid and subdural hemorrhage was identified on Day 4. After stable neuroimaging and multidisciplinary reassessment, UFH was cautiously resumed. An irregular LV apical intracavitary mass, clinically interpreted as an LV thrombus (22.3 mm × 8.5 mm), appeared on Day 7 and enlarged on Day 8. On Day 9, UFH was adjusted from 22.5 to 20 and then to 17.5 U/kg/h while maintaining an individualized activated clotting time target because of recent hemorrhage and then increased to 25 U/kg/h by Day 13 without a loading bolus. The previously described intracavitary masses were no longer visualized during continued UFH and ventricular recovery, although the contributions of these factors could not be separated. Serial echocardiography found no definite intracardiac mass on Days 16 and 17; no residual intracardiac mass was visualized before Day 18 decannulation; the left ventricular ejection fraction (LVEF) was 43%, 46%, 50%, and 52% on Days 14, 16, 17, and 18, respectively. No clinically recognized systemic arterial embolic event was documented during ECMO. A later right internal jugular vein thrombosis was managed as a separate post-ECMO venous thrombotic complication. Nadroparin was introduced after decannulation for post-ECMO venous thromboembolism risk. At 1 month, the LVEF was 47%; a follow-up revealed independent walking, school return, and no recurrent convulsions. Conclusion Left atrial decompression does not guarantee effective LV emptying or eliminate intracavitary stasis during VA-ECMO for fulminant myocarditis, particularly when anticoagulation is constrained by hemorrhage. Serial echocardiography and multidisciplinary, patient-specific reassessment supported management of the competing thrombotic and bleeding risks; non-visualization of the previously described intracardiac masses coincided with continued UFH and ventricular recovery, but no causal treatment effect can be assigned.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-11-19
DOI
https://doi.org/10.3389/fcvm.2026.1915715
Primary Topic
Mechanical Circulatory Support Devices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Case Report: Left ventricular thrombosis during venoarterial extracorporeal membrane oxygenation for fulminant myocarditis in a 9-year-old boy

杨卫国, 黄佩瑜, Yu Wu, Junyu Chen et al.
Frontiers in Cardiovascular Medicine
Mechanical Circulatory Support Devices
article

Case Report: Left ventricular thrombosis during venoarterial extracorporeal membrane oxygenation for fulminant myocarditis in a 9-year-old boy

杨卫国, 黄佩瑜, Yu Wu, Junyu Chen, Ruyu Deng, Dan Li
article en

Abstract

Background Left ventricular (LV) thrombosis is uncommon during venoarterial extracorporeal membrane oxygenation (VA-ECMO) in children. Management is especially difficult when intracranial hemorrhage limits anticoagulation, and pediatric evidence is sparse. Case presentation A 9-year-old boy (25 kg) with fulminant myocarditis and cardiogenic shock underwent VA-ECMO with surgical LV decompression. Unfractionated heparin (UFH, 10 U/kg/h) was initially stopped for pleural-drain bleeding, resumed at low dose, and stopped again after parafalcine subarachnoid and subdural hemorrhage was identified on Day 4. After stable neuroimaging and multidisciplinary reassessment, UFH was cautiously resumed. An irregular LV apical intracavitary mass, clinically interpreted as an LV thrombus (22.3 mm × 8.5 mm), appeared on Day 7 and enlarged on Day 8. On Day 9, UFH was adjusted from 22.5 to 20 and then to 17.5 U/kg/h while maintaining an individualized activated clotting time target because of recent hemorrhage and then increased to 25 U/kg/h by Day 13 without a loading bolus. The previously described intracavitary masses were no longer visualized during continued UFH and ventricular recovery, although the contributions of these factors could not be separated. Serial echocardiography found no definite intracardiac mass on Days 16 and 17; no residual intracardiac mass was visualized before Day 18 decannulation; the left ventricular ejection fraction (LVEF) was 43%, 46%, 50%, and 52% on Days 14, 16, 17, and 18, respectively. No clinically recognized systemic arterial embolic event was documented during ECMO. A later right internal jugular vein thrombosis was managed as a separate post-ECMO venous thrombotic complication. Nadroparin was introduced after decannulation for post-ECMO venous thromboembolism risk. At 1 month, the LVEF was 47%; a follow-up revealed independent walking, school return, and no recurrent convulsions. Conclusion Left atrial decompression does not guarantee effective LV emptying or eliminate intracavitary stasis during VA-ECMO for fulminant myocarditis, particularly when anticoagulation is constrained by hemorrhage. Serial echocardiography and multidisciplinary, patient-specific reassessment supported management of the competing thrombotic and bleeding risks; non-visualization of the previously described intracardiac masses coincided with continued UFH and ventricular recovery, but no causal treatment effect can be assigned.

Frontiers in Cardiovascular MedicineVol. 13
Shenzhen Children's Hospital (CN)
Mechanical Circulatory Support Devices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon